Indira IVF in talks to buy Sabine for up to Rs 1,300 crore
In short
Indira IVF is said to be talking about buying Sabine Hospital and Research Centre for about ₹1,200-1,300 crore. Sabine runs fertility and maternal care services in Kerala across two facilities.
If the deal goes through, it could strengthen Indira IVF’s place in India’s fertility market. The report does not say when a deal may be signed or whether talks will succeed.
What the reporting says
Indira IVF is considering an acquisition of Sabine Hospital and Research Centre valued at ₹1,200-1,300 crore, according to a publisher-supplied summary. The report says Sabine operates fertility and maternal healthcare services across two facilities in Kerala and could add to Indira IVF’s position in India’s fertility market. The reported deal is not confirmed, and no timeline or binding terms are stated.
Why it matters
Indira IVF is reportedly weighing an acquisition of Sabine Hospital and Research Centre in a deal valued at ₹1,200-1,300 crore. The publisher-supplied summary says Sabine offers fertility and maternal healthcare services in Kerala and may generate ₹230-250 crore in revenue in FY27. The main implication is a possible expansion for Indira IVF in fertility treatment, but the talks are unconfirmed and no closing date is stated.